THE DISPOSITION OF CARBOPLATIN IN OVARIAN-CANCER PATIENTS

被引：47

作者：

GAVER, RC

COLOMBO, N

GREEN, MD

GEORGE, AM

DEEB, G

MORRIS, AD

CANETTA, RM

SPEYER, JL

FARMEN, RH

MUGGIA, FM

机构：

[1] ANTI TUMOR CLIN DEPT,WALLINGFORD,CT 06492

[2] NYU MED CTR,DEPT MED,KAPLAN CANC CTR,NEW YORK,NY 10016

来源：

关键词：

D O I：

10.1007/BF00273422

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：263 / 270

页数：8

共 18 条

[1] EARLY CLINICAL-STUDIES WITH CIS-DIAMMINE-1,1-CYCLOBUTANE DICARBOXYLATE PLATINUM-II
CALVERT, AH
HARLAND, SJ
NEWELL, DR
SIDDIK, ZH
JONES, AC
MCELWAIN, TJ
RAJU, S
WILTSHAW, E
SMITH, IE
BAKER, JM
PECKHAM, MJ
HARRAP, KR
[J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1982, 9 (03) : 140 - 147
[2] PHASE-I STUDIES WITH CARBOPLATIN AT THE ROYAL-MARSDEN-HOSPITAL
CALVERT, AH
HARLAND, SJ
NEWELL, DR
SIDDIK, ZH
HARRAP, KR
[J]. CANCER TREATMENT REVIEWS, 1985, 12 : 51 - 57
[3] COLOMBO N, 1986, Proceedings American Society of Clinical Oncology Annual Meeting, V5, P123
[4] CURT GA, 1983, CANCER RES, V43, P4470
[5] EGORIN MJ, 1984, CANCER RES, V44, P5432
[6] GAVER RC, 1987, CANCER CHEMOTH PHARM, V20, P271
[7] HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC PROCEDURES FOR THE ANALYSIS OF CARBOPLATIN IN HUMAN-PLASMA AND URINE
GAVER, RC
DEEB, G
[J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1986, 16 (03) : 201 - 206
[8] GIBALDI M, 1982, PHARMACOKINETICS
[9] HARLAND SJ, 1984, CANCER RES, V44, P1693
[10] KOELLER JM, 1986, CANCER, V57, P222, DOI 10.1002/1097-0142(19860115)57:2<222::AID-CNCR2820570206>3.0.CO